Science
Joel Helmke: The Acceleration of Discovery Is Transforming Cancer Care
Joel Helmke/foxchase.org

Joel Helmke: The Acceleration of Discovery Is Transforming Cancer Care

Joel Helmke, Chief Operating Officer at Knight Cancer Group, shared on LinkedIn:

“Thrilled to witness the culmination of many years of hard work taking shape.

Props to Nima Nabavizadeh, and the rest of the Pathfinder 2 team for bringing a new tool to the arsenal of weapons we are accumulating to fight cancer.

It is such an amazing time to be in oncology. The acceleration of discovery is more than anyone imagined 25 years ago.”

Title: Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study

Authors: Nima Nabavizadeh, Charles McDonnell, Dax Kurbegov, Marc Matrana, Shirish Gadgeel, Raymond H. Kim, Gretchen Stipec, Kevin C. Oeffinger, Michael J. Demeure, James W. Lillard Jr., Rebecca Kaltman, Jennifer Tran, Alan Roth, Sami Tahhan, Andrew Poklepovic, Donald Richards, Margarita Lopatin, Celine Marquez, Margaret McCusker, Karthik V. Giridhar

Read the Full Article.

Joel Helmke: The Acceleration of Discovery Is Transforming Cancer Care

Other articles featuring Joel Helmke on OncoDaily.

Alan Roth Andrew Poklepovic cancer Celine Marquez Charles McDonnell Dax Kurbegov Donald Richards Gretchen Stipec James W. Lillard Jr. Jennifer Tran Joel Helmke Karthik V. Giridhar Kevin C Oeffinger Marc Matrana Margaret McCusker Margarita Lopatin Michael J. Demeure Nima Nabavizadeh OncoDaily Oncology Raymond H. Kim Rebecca Kaltman Sami Tahhan Shirish Gadgeel